JP2016108327A5 - - Google Patents

Download PDF

Info

Publication number
JP2016108327A5
JP2016108327A5 JP2015231564A JP2015231564A JP2016108327A5 JP 2016108327 A5 JP2016108327 A5 JP 2016108327A5 JP 2015231564 A JP2015231564 A JP 2015231564A JP 2015231564 A JP2015231564 A JP 2015231564A JP 2016108327 A5 JP2016108327 A5 JP 2016108327A5
Authority
JP
Japan
Prior art keywords
solid composition
extract
group
croscarmellose sodium
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015231564A
Other languages
English (en)
Japanese (ja)
Other versions
JP6327237B2 (ja
JP2016108327A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016108327A publication Critical patent/JP2016108327A/ja
Publication of JP2016108327A5 publication Critical patent/JP2016108327A5/ja
Application granted granted Critical
Publication of JP6327237B2 publication Critical patent/JP6327237B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015231564A 2014-12-05 2015-11-27 固形組成物 Active JP6327237B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014246787 2014-12-05
JP2014246787 2014-12-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017004042A Division JP6662312B2 (ja) 2014-12-05 2017-01-13 固形組成物

Publications (3)

Publication Number Publication Date
JP2016108327A JP2016108327A (ja) 2016-06-20
JP2016108327A5 true JP2016108327A5 (ru) 2017-03-09
JP6327237B2 JP6327237B2 (ja) 2018-05-23

Family

ID=56121796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015231564A Active JP6327237B2 (ja) 2014-12-05 2015-11-27 固形組成物
JP2017004042A Active JP6662312B2 (ja) 2014-12-05 2017-01-13 固形組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017004042A Active JP6662312B2 (ja) 2014-12-05 2017-01-13 固形組成物

Country Status (1)

Country Link
JP (2) JP6327237B2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6668706B2 (ja) * 2014-12-12 2020-03-18 大正製薬株式会社 固形組成物
JP6286383B2 (ja) * 2015-03-27 2018-02-28 小林製薬株式会社 固形医薬組成物
JP2017075136A (ja) * 2015-06-08 2017-04-20 ロート製薬株式会社 内服組成物
JP6294943B2 (ja) * 2016-10-28 2018-03-14 小林製薬株式会社 固形医薬組成物
JP7235193B2 (ja) * 2017-04-26 2023-03-08 大正製薬株式会社 固形組成物
JP6982290B2 (ja) * 2017-06-15 2021-12-17 大峰堂薬品工業株式会社 オンジエキス含有内服用固形医薬製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243832A (ja) * 1991-01-22 1992-08-31 Kanebo Ltd 自己免疫疾患治療剤
JPH05139982A (ja) * 1991-11-26 1993-06-08 Kanebo Ltd 虚血性脳疾患改善剤
JP4293572B2 (ja) * 1998-06-30 2009-07-08 株式会社龍角散 ロキソプロフェン・ナトリウム含有錠剤
JP5021210B2 (ja) * 2006-01-16 2012-09-05 エスエス製薬株式会社 圧縮成型製剤
JP5989960B2 (ja) * 2010-02-26 2016-09-07 小林製薬株式会社 サラシア含有組成物
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
JP5759113B2 (ja) * 2010-06-16 2015-08-05 旭化成ケミカルズ株式会社 エキス末配合錠剤
JP6062168B2 (ja) * 2011-07-01 2017-01-18 武田薬品工業株式会社 生薬由来成分を含有する製剤及びその製造方法
JP2013053144A (ja) * 2011-08-09 2013-03-21 Daiichi Sankyo Healthcare Co Ltd 鎮静剤組成物
KR20140017976A (ko) * 2012-08-03 2014-02-12 삼성제약공업주식회사 수험생용 비타 하이브리드 정제 및 그 제조 방법
JP2014166994A (ja) * 2013-02-04 2014-09-11 Rohto Pharmaceut Co Ltd 新規な漢方エキス製剤

Similar Documents

Publication Publication Date Title
JP2016108327A5 (ru)
AU2019268075A1 (en) Pharmaceutical compositions comprising dimethyl fumarate
RU2018114447A (ru) Введение дейтерированных усилителей cftr
CN106687454B8 (zh) 作为细胞周期蛋白依赖性激酶(cdk)抑制剂的2h-吲唑衍生物及其医疗用途
NZ721298A (en) Pharmaceutical compositions comprising azd9291
UY33062A (es) Comprimidos y composiciones farmacéuticas comprimibles recubiertos y métodos de fabricación
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
JP2015511635A5 (ru)
RU2014138035A (ru) Твердая фармацевтическая композиция, содержащая 1-(3-(2-(1-бензотиофен-5-ил)этокси)пропил)азетидин-3-ол или его соль
JP2015510916A5 (ru)
CR10668A (es) Comprimidos pediatricos de capecitabina
UA112352C2 (uk) Фармацевтична композиція для профілактики і лікування психічних, поведінкових, когнітивних розладів
BR112017028218A2 (pt) ?comprimidos de liberação imediata contendo uma droga e processos para formação dos comprimidos?
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
JP2014024874A5 (ru)
RU2018103213A (ru) Фармацевтическая комплексная композиция, включающая амлодипин, лозартан и розувастатин
PH12017502249A1 (en) Tofacitinib orally disintegrating tablets
WO2015086838A3 (en) A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
JP2015129124A5 (ru)
HRP20130225T1 (hr) Formulacija s odgođenim otpuštanjem koja sadrži 3-(2-dimetilaminometilcikloheksil) fenol
JP2017523149A5 (ru)
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
BR112017019364A2 (pt) dispersões sólidas
JP2015129175A5 (ru)